A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study).

Ramu, J; Yang, Y; Menon, G; Bailey, C; Narendran, N; Bunce, C; Quartilho, A; Ramu, J; Yang, Y; Menon, G; Bailey, C; Narendran, N; Bunce, C; Quartilho, A; Prevost, AT; Hykin, P; Sivaprasad, S; OZDRY Study Group, ; - view fewer (2015) A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study). Eye (Lond) , 29 (12) pp. 1603-1612. 10.1038/eye.2015.214 .

http://ift.tt/2pYOrPz